186 filings
F-3
ACIU
AC Immune SA
14 Mar 24
Shelf registration (foreign)
4:43pm
6-K
ACIU
AC Immune SA
14 Mar 24
Current report (foreign)
7:44am
20-F
2023 FY
ACIU
AC Immune SA
Annual report (foreign)
14 Mar 24
7:30am
6-K
ACIU
AC Immune SA
22 Jan 24
Current report (foreign)
7:53am
6-K
ACIU
AC Immune SA
3 Jan 24
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson's diseases
4:19pm
6-K
bhzxasc0k3 235nn
19 Dec 23
Current report (foreign)
8:53am
424B5
9o9 muky5jqoi
15 Dec 23
Prospectus supplement for primary offering
5:27pm
6-K
m7y9ydodmdc4
15 Dec 23
Current report (foreign)
7:27am
6-K
maxz7d5kjeoyuj1l
1 Dec 23
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
7:13am
6-K
2jqy n0y4
3 Nov 23
Current report (foreign)
7:30am
6-K
a6i5n2vn1f dvp6
4 Aug 23
Current report (foreign)
7:30am
6-K
dcxkm
26 Jul 23
AC Immune SA Appoints New Chief Medical Officer
7:17am
6-K
o8j6 3dj5
27 Jun 23
AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease
8:22am
6-K
rfs6jf7lx
26 Jun 23
Current report (foreign)
8:40am
6-K
es1l2jb5ke56
24 May 23
Invitation to the Annual General Meeting 2023 To the Shareholders of AC Immune SA
4:07pm
6-K
5xuv 515wmvcr
28 Apr 23
Current report (foreign)
7:30am
6-K
uojwtg
16 Mar 23
AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update
7:33am
6-K
0pny2j4w3ryyny9p
10 Mar 23
Current report (foreign)
5:06pm
6-K
6nfxkwmm48u0 aal4
26 Jan 23
Current report (foreign)
7:05am